Literature DB >> 30658259

Radiological characteristics of myelin oligodendrocyte glycoprotein antibody disease.

Sara Salama1, Majid Khan2, Michael Levy3, Izlem Izbudak2.   

Abstract

BACKGROUND: MOG antibody disease is an autoimmune disease of the central nervous system (CNS) characterized by the presence of a serological antibody against myelin oligodendrocyte glycoprotein (MOG). MRI is instrumental in distinguishing neuromyelitis optica spectrum disorder (NMOSD) from multiple sclerosis (MS), but MRI features of MOG disease appear to overlap with NMOSD and MS.
OBJECTIVES: In this study we aim to characterize the radiological features of MOG antibody disease and compare the findings with those previously described.
METHODS: This is a retrospective study of 26 MOG positive patients. We aim to describe their brain, spinal and orbital MRI features and compare our findings with those previously reported in the literature.
RESULTS: The majority of the abnormal findings was located on orbital MRIs, with more involvement of the anterior structures and bilateral involvement of the optic nerves. Brain abnormalities were distinct from both NMOSD and MS lesions. Spinal cord was the least affected.
CONCLUSIONS: This is a dedicated radiological study aiming to characterize the features of MOG antibody disease which might aid in the proper investigation of cases presenting with acquired demyelinating disorders.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  MOG antibody; Magnetic resonance imaging; NMOSD

Mesh:

Substances:

Year:  2019        PMID: 30658259      PMCID: PMC6431795          DOI: 10.1016/j.msard.2019.01.021

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  36 in total

1.  Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies.

Authors:  Joanna Kitley; Maria Isabel Leite; Wilhelm Küker; Gerardine Quaghebeur; Jithin George; Patrick Waters; Mark Woodhall; Angela Vincent; Jacqueline Palace
Journal:  JAMA Neurol       Date:  2013-11       Impact factor: 18.302

2.  "Bright spotty lesions" on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis.

Authors:  Tadahiro Yonezu; Shoichi Ito; Masahiro Mori; Yoshitsugu Ogawa; Takahiro Makino; Akiyuki Uzawa; Satoshi Kuwabara
Journal:  Mult Scler       Date:  2013-07-04       Impact factor: 6.312

3.  Evolution of longitudinally extensive transverse myelitis in an aquaporin-4 IgG-positive patient.

Authors:  Nasrin Asgari; Hanne Pernille Bro Skejoe; Vanda A Lennon
Journal:  Neurology       Date:  2013-07-02       Impact factor: 9.910

4.  Optic neuritis in neuromyelitis optica.

Authors:  Marc H Levin; Jeffrey L Bennett; A S Verkman
Journal:  Prog Retin Eye Res       Date:  2013-03-30       Impact factor: 21.198

5.  Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.

Authors:  Douglas Kazutoshi Sato; Dagoberto Callegaro; Marco Aurelio Lana-Peixoto; Patrick J Waters; Frederico M de Haidar Jorge; Toshiyuki Takahashi; Ichiro Nakashima; Samira Luisa Apostolos-Pereira; Natalia Talim; Renata Faria Simm; Angelina Maria Martins Lino; Tatsuro Misu; Maria Isabel Leite; Masashi Aoki; Kazuo Fujihara
Journal:  Neurology       Date:  2014-01-10       Impact factor: 9.910

6.  Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.

Authors:  Eoin P Flanagan; Brian G Weinshenker; Karl N Krecke; Vanda A Lennon; Claudia F Lucchinetti; Andrew McKeon; Dean M Wingerchuk; Elizabeth A Shuster; Yujuan Jiao; Erika S Horta; Sean J Pittock
Journal:  JAMA Neurol       Date:  2015-01       Impact factor: 18.302

Review 7.  MRI characteristics of neuromyelitis optica spectrum disorder: an international update.

Authors:  Ho Jin Kim; Friedemann Paul; Marco A Lana-Peixoto; Silvia Tenembaum; Nasrin Asgari; Jacqueline Palace; Eric C Klawiter; Douglas K Sato; Jérôme de Seze; Jens Wuerfel; Brenda L Banwell; Pablo Villoslada; Albert Saiz; Kazuo Fujihara; Su-Hyun Kim
Journal:  Neurology       Date:  2015-02-18       Impact factor: 9.910

8.  Magnetic resonance imaging of optic neuritis in patients with neuromyelitis optica versus multiple sclerosis.

Authors:  Sangeeta Khanna; Aseem Sharma; Julie Huecker; Mae Gordon; Robert T Naismith; Gregory P Van Stavern
Journal:  J Neuroophthalmol       Date:  2012-09       Impact factor: 3.042

9.  Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.

Authors:  Joanna Kitley; Patrick Waters; Mark Woodhall; M Isabel Leite; Andrew Murchison; Jithin George; Wilhelm Küker; Saleel Chandratre; Angela Vincent; Jacqueline Palace
Journal:  JAMA Neurol       Date:  2014-03       Impact factor: 18.302

10.  Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.

Authors:  Joanna Kitley; Mark Woodhall; Patrick Waters; M Isabel Leite; Emma Devenney; John Craig; Jacqueline Palace; Angela Vincent
Journal:  Neurology       Date:  2012-08-22       Impact factor: 9.910

View more
  8 in total

1.  Expanding the spectrum of MOG antibody disease.

Authors:  Michael Levy
Journal:  Mult Scler       Date:  2019-04-01       Impact factor: 6.312

2.  Unilateral cortical FLAIR-hyperintense Lesions in Anti-MOG-associated Encephalitis with Seizures (FLAMES): characterization of a distinct clinico-radiographic syndrome.

Authors:  A Budhram; A Mirian; C Le; S M Hosseini-Moghaddam; M Sharma; M W Nicolle
Journal:  J Neurol       Date:  2019-06-26       Impact factor: 4.849

3.  Positive Predictive Value of MOG-IgG for Clinically Defined MOG-AD Within a Real-World Cohort.

Authors:  Giovanna S Manzano; Rebecca Salky; Farrah J Mateen; Eric C Klawiter; Tanuja Chitnis; Michael Levy; Marcelo Matiello
Journal:  Front Neurol       Date:  2022-06-20       Impact factor: 4.086

Review 4.  Clinical and Radiological Features of Myelin Oligodendrocyte Glycoprotein-Associated Myelitis in Adults.

Authors:  Ki Hoon Kim; Su-Hyun Kim; Jae-Won Hyun; Ho Jin Kim
Journal:  J Clin Neurol       Date:  2022-05       Impact factor: 2.566

5.  Anti-MOG-associated demyelinating disorders: two sides of the same coin.

Authors:  Giorgia Teresa Maniscalco; Lia Allegorico; Gennaro Alfieri; Massimo Napolitano; Angelo Ranieri; Rosaria Renna; Giovanna Servillo; Marianna Pezzella; Elisa Capone; Lidia Altomare; Michele Spiniello; Sergio Ferrari; Valentino Manzo; Sara Mariotto
Journal:  Neurol Sci       Date:  2020-11-14       Impact factor: 3.307

Review 6.  A window into the future? MRI for evaluation of neuromyelitis optica spectrum disorder throughout the disease course.

Authors:  Jacqueline M Solomon; Friedemann Paul; Claudia Chien; Jiwon Oh; Dalia L Rotstein
Journal:  Ther Adv Neurol Disord       Date:  2021-05-09       Impact factor: 6.570

7.  Clinical profile, imaging features and short term visual outcomes of Indian optic neuritis patients with and without seromarkers for myelin oligodendrocyte glycoprotein and neuromyelitis optica.

Authors:  Selvakumar Ambika; Santhakumar Durgapriyadarshini; Krishnakumar Padmalakshmi; Veena Noronha; Deepak Arjundas
Journal:  Indian J Ophthalmol       Date:  2022-01       Impact factor: 1.848

8.  Contrasting the brain imaging features of MOG-antibody disease, with AQP4-antibody NMOSD and multiple sclerosis.

Authors:  Silvia Messina; Romina Mariano; Adriana Roca-Fernandez; Ana Cavey; Maciej Jurynczyk; Maria Isabel Leite; Massimiliano Calabrese; Mark Jenkinson; Jacqueline Palace
Journal:  Mult Scler       Date:  2021-05-28       Impact factor: 6.312

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.